Catalyst Wire Dossier Catalyst Wire Dossier

IM19 Cells

· Beijing Immunochina Medical Science & Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IM19 Cells, covering 2017-11-17 to 2017-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of IM19 Cells [Phase 1]

See pricing